- This event has passed.
Cannabiz Virtual Summit 2020
October 20 - October 21
Cannabiz Summit World – Join over 2,000 delegates at the inaugural Cannabiz Summit World to discuss legislation, education, investment, and technology in this exciting business sector. Showcase your products at the expo and network with top global industry professionals. San Giljan, Malta; Virtual Conference – Oct 20-21, 2020
Following a successful, government-backed 2019 summit, which attracted more than 1,500 delegates – the second edition of Med-Cann World will take place virtually, in tandem with SiGMA Group’s recently launched vertical, Med-Tech World, on 20 & 21 October 2020.
Co-locating these events will leverage the company’s long-standing expertise in other verticals, such as emerging tech, offering insightful, data-driven content created exclusively with the medical community in mind.
Delegates can expect events focusing on policy-making and regulation, health equity, medical innovation, and personalized, patient-focussed tech. With so many countries attuned to the investment benefits of adapting smart technologies, the summits offer a valuable introduction to a million-dollar forum for exponential growth in the global sector.
The event has attracted a prestigious guest-list of experts in their field, from legislators and medical professionals to investors and industry peers from across the globe.
Technological innovation is changing the face of medicine as we know it – don’t miss out.
MED-TECH WORLD The inaugural edition of Med-Tech World highlights leading innovations in emerging tech for the European medical ecosystem. Leading experts will address the opportunities and challenges the industry faces – debating hot-button issues revolutionizing the face of medicine and patient care. From deep learning and surgical robotics to bio-printing and augmented reality, as well as regulatory issues such as patents and clinical trials, Med Tech World brings medicine into the future.
MED CANN WORLD Launched in 2019, Med Cann World offers a 360-degree look at the global medical cannabis industry, offering expert-led insight into emerging markets, research, and development in an evolving regulatory landscape, as well as a personalized, patient-focused perspective on medical policies and care.